Ocean Biomedical

Ocean Biomedical

Company profile

About

Ocean Biomedical (NASDAQ:OCEA) focuses on accelerating the development and commercialization of scientific innovations in medicine and health, with a primary mission to translate complex research into accessible healthcare solutions. Their operations span a broad range of projects, including developing novel therapies for cancer, fibrosis, and infectious diseases, leveraging a close partnership with academic scientists and research institutions to bridge the gap between groundbreaking scientific discoveries and patient care. The company's objectives center on advancing its pipeline of proprietary therapeutics through clinical trials, aiming to address significant unmet medical needs. Ocean Biomedical's commitment lies in transforming promising biomedical research into real-world medical solutions that improve patient outcomes and quality of life.

Snapshot

2019Year founded

9Employees

Rhode Island, United StatesHead office

Loading Map...

Global footprint

Operations

All Locations

United States

Products and/or services of Ocean Biomedical

Developing a novel therapy targeting the chaperone protein, leading the fight against multiple forms of cancer and fibrosis.
Pioneering a unique vaccine approach aimed at preventing malaria, utilizing cutting-edge biotechnology to tackle this global health challenge.
Advancing a treatment that inhibits a specific pathway to combat lung fibrosis, showcasing a commitment to addressing respiratory diseases.
Creating innovations in biodegradable materials to reduce hospital waste, highlighting a focus on sustainability in the healthcare sector.
Launching a digital health platform to improve patient care management, integrating technology to enhance healthcare delivery.
Researching into marine-derived compounds for pharmaceutical applications, exploring the ocean's biodiversity for novel medical treatments.